Leadership at the intersection of health, ethics, technology, and law.
Featured
From The Harvard Gazette: Time to legalize psychedelics?
Debate over psychedelic legalization tends to focus on two extreme views: the need to speed therapeutic access to meet urgent problems such as veteran suicide, and calls to thoroughly research substances first to ensure they meet safety standards.
Our Focus Areas
Latest
-
Medical Debt is Bad, But Hospitals Make It So Much Worse
Medical debt has become a fixture in our health care marketplace, with 41 percent of working-age Americans reportedly struggling to pay their medical bills.
-
The FDA Patent History of Asthma Inhalers
Even though asthma takes an enormous toll on patients throughout the United States, many struggle to afford asthma medication.
-
Birth Centers Disentangled from Regulations: A Solution to Disappearing L&D Wards
The U.S. has the highest maternal mortality rate among developed nations. And yet, since 2020, a staggering 116 rural labor and delivery (L&D) wards in America have shuttered their doors, representing an 11 percent reduction in the overall number of rural L&D wards.
-
Current Newsletter
Our most recent newsletter Full newsletter archive Subscribe
-
Health Mediation: A New Perspective on Health Conflict Resolution
In health law, we tend to speak about regulations and court rulings. But behind every case file, there is something more: a story, an emotion, and, above all, a person.
Explore more from our blog
Latest episode of our podcast
Fireside Chat: I. Glenn Cohen and Rochelle Walensky
Professor Glenn Cohen, Faculty Director of the Petrie-Flom Center at Harvard Law School interviews Dr. Rochelle Walensky, 19th Director of the Centers for Disease Control and Prevention and Senior Academic Fellow at the Petrie-Flom Center. They discuss Dr. Walensky’s career as an infectious disease clinician focused on HIV/AIDS, her experience leading the CDC during COVID-19, and her reflections on public health infrastructure in the United States and internationally.
